Dr. Rémi Quirion is a McGill University Full Professor and Scientific Director at the Douglas Hospital Research Centre (a McGill affiliated teaching hospital). Under his leadership, the Douglas Hospital Research Centre became a premier research facility in Canada in the fields of neurosciences and mental health. Dr Quirion promoted the development of neurosciences and clinical research in Neurology and Psychiatry as well as social and evaluation aspects of research in mental health and addiction. His research interests include: a) understanding the relationships between key phenotypes of the Alzheimer's brain and b) molecular and pharmacological features of neuropeptide receptors focusing on NPY and CGRP, and their role in memory, pain and drug dependence, and in animal models of schizophrenia. A major interest lies in the training of the next generation of scientists. In addition to being on the Advisory Board of over 15 scientific journals in Psychiatry, Pharmacology, and Neurosciences, Dr. Quirion has published 5 books and more than 500 scientific papers and articles.
Dr. Quirion is the inaugural Scientific Director of the Institute of Neurosciences, Mental Health and Addiction, one of the 13 virtual institutes of the Canadian Institutes of Health Research created in 2000. Moreover, Dr. Quirion is one of the most highly cited neuroscientists in the world, in addition to being Fellow of the Royal Society of Canada and a "Chevalier" of the "Ordre national du Québec". He also received in 2003 the Médaille de l'Assemblée nationale du Québec" and the "2003 First Annual Award - National Mental Health Champion (Research)". In 2004 he received the "Wilder-Penfield Award, Prix du Québec", the highest distinction in Biomedical Research in Quebec, as well as a Heinz-Lehmann Award from the Douglas Hospital Foundation, and the Dr. Mary V. Seeman Award from the Canadian Psychiatric Research Foundation.
Term end: December 31, 2008
